Clinical Trials in Brazil / NCT07310979
Enrolling by invitation Observational

Clinical Evaluation of a Hyperbolic Paraboloid Triple-Abutment on Morse Taper Dental Implants

NCT07310979 · tracked via the Priya Life Science Brazil tracker
Phase
Observational
Started
2025-12-29
Last updated
2026-01-02

Condition(s) studied

Dental ImplantsDental Prosthesis, Implant-Supported

Investigational drug(s) / intervention(s)

Triple-Abutment System with Hyperbolic Paraboloid Geometry

Triple-Abutment System with Hyperbolic Paraboloid Geometry: Prosthetic loading will be performed on osseointegrated morse taper dental implants using a fixed implant-supported rehabilitation with a triple-abutment system featuring hyperbolic paraboloid geometry. Metal-ceramic prostheses will be cemented over the abutment components. All procedures will be performed by a single operator.

Study summary

This prospective clinical study aims to evaluate the clinical and radiographic outcomes of a novel triple-abutment system with hyperbolic paraboloid geometry installed on Morse taper dental implants. The system is designed to support three adjacent crowns on a single implant, aiming to optimize load distribution and preserve peri-implant tissue stability.

Thirty systemically healthy adults missing three adjacent teeth will undergo implant placement, followed by a healing period of approximately three months for osseointegration prior to prosthetic loading. Metal-ceramic restorations will then be cemented over triple abutments. Clinical and radiographic evaluations will be performed at T1 (3-4 months after prosthetic loading) and T2 (12-18 months after prosthetic loading).

The primary outcome will be marginal bone level change assessed by standardized periapical radiographs. Secondary outcomes include probing depth, bleeding on probing, plaque index, keratinized mucosa height, and patient-reported satisfaction. The study aims to investigate whether this innovative abutment design provides stable peri-implant conditions and favorable clinical performance when applied to Morse taper implants.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged ≥ 18 years. * Systemically healthy as determined by medical history and clinical assessment. * Non-smokers (no tobacco use). * Able and willing to comply with study visits and maintenance program, and provide written informed consent. Exclusion Criteria: * diabetes mellitus (any type) or uncontrolled systemic disease. * current or recent tobacco/nicotine use * bisphosphonates or other antiresorptives, * immunosuppressive therapy, * osteoporosis * pregnancy or lactation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Federal University of Minas Gerais, Dental School Belo Horizonte Minas Gerais

More Federal University of Minas Gerais trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07310979 on ClinicalTrials.gov ↗ ← All trials in Brazil